Pharmacist urges faster assessment of Beyfortus for RSV

Summary: Pharmacist Sheena Mitchell urges faster assessment of Beyfortus RSV antibody treatment in Ireland due to high RSV rates. 7,704 RSV cases were reported this winter, with 785 children infected in one week. The EMA study showed lower severe RSV cases with Beyfortus. The treatment is undergoing HTA and may replace Palivizumab for high-risk infants. The Department of Health prioritizes rapid assessment for infant immunization against RSV.

Full article